Efficacy, Safety, and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis: A Randomized, Double-Blind Phase 3 Study, MEASURE 3
Arthritis Research & Therapy
doi 10.1186/s13075-017-1490-y
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2017
Authors
Publisher
Springer Science and Business Media LLC